NCR3 and gastrointestinal stromal tumor: To date, three splice variants of NKp30 have been identified: NKp30C, an immunosuppressive isoform, as well as the activating isoforms NKp30A and B, which have been reported to affect NK cell function and may be correlated with the clinical outcome of gastrointestinal tumors (GIST).